Anti-Methamphetamine Antibody [ME3B9] (A281077)

Anti-Methamphetamine Antibody [ME3B9]

Mouse monoclonal [ME3B9] antibody to Methamphetamine.

This antibody recognises methamphetamine, a central nervous system stimulant that triggers the release of dopamine and norepinephrine in the brain. It has significant enhancing effects on the mood and energy. Medically, methamphetamine is used to treat attention deficit hyperactivity disorder, obesity and narcolepsy. Side-effects may include anorexia, restlessness, arrhythmias, heart attack or stroke. Methamphetamine is addictive and tolerance develops quickly. Users might also use sedatives to ease anxiety and trouble sleeping. Addiction is difficult to treat, with withdrawal symptoms such as anxiety, excessive sleeping, eating and depression. Relapse rates are high.

Immunoassay, ELISA

Species Independent

Mouse

Monoclonal

ME3B9

IgG1

Protein A affinity chromatography of tissue culture supernatant.

Liquid

Supplied in Phosphate Buffered Saline with <0.1% Sodium Azide.

Shipped at ambient temperature. Upon delivery aliquot and store at -20°C. When thawed, aliquot the sample as needed. Short term (up to 4 weeks): store at 4°C. Long term: store at -20°C. Avoid freeze / thaw cycles. Storage in frost free freezers is not recommended.

Mouse anti Methamphetamine antibody, clone ME3B9 recognizes methamphetamine, a central nervous system stimulant that triggers the release of dopamine and norepinephrine in the brain. It has significant enhancing effects on the mood and energy. Medically, methamphetamine is used to treat attention deficit hyperactivity disorder, obesity and narcolepsy. Side-effects may include anorexia, restlessness, arrhythmias, heart attack or stroke. Methamphetamine is addictive and tolerance develops quickly. Users might also use sedatives to ease anxiety and trouble sleeping. Addiction is difficult to treat, with withdrawal symptoms such as anxiety, excessive sleeping, eating and depression. Relapse rates are high.